Skip to Content
UW Health SMPH
American Family Children's Hospital

UW Hospital and Clinics Lab Test Directory

Test Name: Platelet Mapping, ADP with Thromboelastograph

Test Code(s): Test discontinued 6/15/15.


Specimen Requirements


Interpretation

Additional Information:

Effective June 15, 2015, Platelet Mapping, ADP was discontinued. To evaluate the effect of P2Y12 inhibitor drugs such as clopidogrel (Plavix), prasugrel (Effient), ticagrelor (Brillinta) and ticlopidine (Ticlid) we offer the Platelet Reactivity (PRU) Profile. The profile includes the Platelet Reactivity (PRU) test and the Platelet Aggregation, ADP.

We will continue to offer the Platelet Mapping, AA (Arachidonic Acid) for the assessement of platelet inhibition by aspirin.

Platelet Mapping clopidogrel(Plavix®),Platelet Inhibition by clopidogrel(Plavix®,PMADP

Back to Lab Test Directory Index